Fasting or Non-fasting Lipids for Atherosclerotic Cardiovascular Disease Risk Assessment and Treatment?

Autosomal dominant familial dysbetalipoproteinemia: A pathophysiological framework and practical approach to diagnosis and therapy

(2017) Charlotte Koopal et al.   Journal of Clinical Lipidology

Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease

(2017) Marc S. Sabatine et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease

(2017)   NEW ENGLAND JOURNAL OF MEDICINE

Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points—a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine

(2016) Børge G. Nordestgaard et al.   EUROPEAN HEART JOURNAL

Fasting or Nonfasting Lipid Measurements

(2016) Steven L. Driver et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Familial Hypercholesterolemia: Advances in Recognition and Therapy

(2016) Jacqueline L. Cartier et al.   PROGRESS IN CARDIOVASCULAR DISEASES

The Agenda for Familial Hypercholesterolemia

(2015) Samuel S. Gidding et al.   CIRCULATION

National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 1—Full Report

(2015) Terry A. Jacobson et al.   Journal of Clinical Lipidology

Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: Rationale and design of the ODYSSEY Outcomes trial

(2014) Gregory G. Schwartz et al.   AMERICAN HEART JOURNAL

Prognostic Value of Fasting Versus Nonfasting Low-Density Lipoprotein Cholesterol Levels on Long-Term Mortality

(2014) Bethany Doran et al.   CIRCULATION

2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults

(2013) Neil J. Stone et al.   CIRCULATION

Non-HDL cholesterol vs. Apo B for risk of coronary heart disease in healthy individuals: the EPIC-Norfolk prospective population study

(2013) Brigitte M. Sondermeijer et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Friedewald-Estimated Versus Directly Measured Low-Density Lipoprotein Cholesterol and Treatment Implications

(2013) Seth S. Martin et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Nonfasting Lipids: There Is the Population and Then There Is the Patient

(2013) Seth S. Martin et al.   JAMA Internal Medicine

Fasting Time and Lipid Levels in a Community-Based Population

(2012) Davinder Sidhu et al.   ARCHIVES OF INTERNAL MEDICINE

Association of LDL Cholesterol, Non–HDL Cholesterol, and Apolipoprotein B Levels With Risk of Cardiovascular Events Among Patients Treated With Statins

(2012) S. Matthijs Boekholdt et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Hypoglycemia in Patients With Diabetes on Antidiabetic Medications Who Fast for Laboratory Tests

(2011) S. Aldasouqi et al.   DIABETES CARE

Non–High-Density Lipoprotein Cholesterol Versus Apolipoprotein B in Cardiovascular Risk Stratification

(2011) Vimal Ramjee et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

The Biogenesis of Chylomicrons

(2010) Charles M. Mansbach et al.   Annual Review of Physiology

Nonfasting cholesterol and triglycerides and association with risk of myocardial infarction and total mortality: the Copenhagen City Heart Study with 31 years of follow-up

(2010) A. Langsted et al.   JOURNAL OF INTERNAL MEDICINE

Diagnosis and treatment of apolipoprotein B dyslipoproteinemias

(2010) Allan Sniderman et al.   Nature Reviews Endocrinology

Major Lipids, Apolipoproteins, and Risk of Vascular Disease

(2009) The Emerging Risk Factors Collaboration*   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Fasting Compared With Nonfasting Lipids and Apolipoproteins for Predicting Incident Cardiovascular Events

(2008) Samia Mora et al.   CIRCULATION

Nonfasting Triglycerides and Risk of Ischemic Stroke in the General Population

(2008) Jacob J. Freiberg   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein

(2008) Paul M Ridker et al.   NEW ENGLAND JOURNAL OF MEDICINE